Schizophrenia --;Reflections on the History of Psychopharmacology --;Receptor Interactions of Dopamine and Serotonin Antagonists: Binding In Vitro and In Vivo and Receptor Regulation --;PET Scanning --;A New Tool in Clinical Psychopharmacology --;Pharmacokinetics of Neuroleptic Drugs and the Utility of Plasma Level Monitoring --;Neuroleptic Drugs in the Treatment of Acute Psychosis: How Much Do We Really Know? --;Observations on the Use of Depot Neuroleptics in Schizophrenia --;Neuroleptic Side Effects: Acute Extrapyramidal Syndromes and Tardive Dyskinesia --;Future Treatment of Schizophrenia --;A Clinician's Comments on Current Trends in Psychopharmacology of Schizophrenia --;Affective Disorders --;Treating Depression in Acute Stage: Biochemical and Clinical Aspects --;Pharmacological Management of Treatment-Resistant Depression --;Is There a Long-Term Protective Effect of Mood-Altering Agents in Unipolar Depressive Disorder? --;Lithium in Manic-Depressive Illness: Plusses, Pitfalls, and Perspectives --;Basic and Clinical Aspects of the Activity of the New Monoamine Oxidase Inhibitors --;Unsolved Problems in the Pharmacotherapy of Depression --;Anxiety, Dementia, and Other Special Topics --;Long-Term Treatment of Anxiety: Benefits and Drawbacks --;Future Directions in Anxiety Research --;Dementia: Classification and Aspects of Treatment --;Test Models and New Directions in Dementia Research --;On Current Research in Affective Disorders.
SUMMARY OR ABSTRACT
Text of Note
The etiology, pathogenetic mechanisms, clinical aspects, and future directions of research in schizophrenia, affective disorders, anxiety, and dementia are addressed.